Loading...

PSTV PLUS THERAPEUTICS INC Operational Disruptions 8-K Filing

PLS

PSTV

PLUS THERAPEUTICS INC

(PSTV)

2023 8-K

Show Summary

Show Summary

Voluntary Delisting

Financial Statements

Delisting due to Non-Compli...

Delisting due to Non-Compli...

Authorized Common Stock Inc...

Financial Results

Nasdaq Compliance

Private Placement

Private Placement

Q3 Financial Results

Nasdaq Compliance Issue

Nasdaq Compliance Issue

Annual Meeting Results

Q2 Financial Results

Resignation of Chief Medica...

Loan Drawn and Loan Repaid

Annual Meeting Announcement

Financial Results

Securities Purchase Agreement

Presentation Slides

Financial Results Announcement

Positive Clinical Trial Dat...

Share Repurchase Program

Financial Results

Financial Results

Compliance regained with Na...

Reverse Stock Split

Annual Meeting Approval

Financial Results

No Relationship with Silico...

Entry Into a Material Defin...

Financial Results

External Links:

Plus Therapeutics, Inc. announced positive data from the ongoing ReSPECT-GBM Phase 2 trial for the treatment of recurrent glioblastoma, including improved overall survival and progression-free survival.

AI Assistant

PLUS THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.